Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Deutsche Bank AG

Deutsche Bank AG trimmed its holdings in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 82.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 171,853 shares of the health services provider's stock after selling 793,669 shares during the period. Deutsche Bank AG owned approximately 0.10% of Teladoc Health worth $1,562,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in TDOC. Arkadios Wealth Advisors acquired a new position in Teladoc Health in the 4th quarter valued at about $115,000. Nisa Investment Advisors LLC boosted its stake in shares of Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock valued at $3,874,000 after purchasing an additional 424,180 shares during the period. KBC Group NV grew its holdings in shares of Teladoc Health by 72.3% in the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider's stock valued at $80,000 after purchasing an additional 3,714 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its stake in Teladoc Health by 21.8% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after buying an additional 125,111 shares during the period. Finally, Murphy Pohlad Asset Management LLC acquired a new stake in Teladoc Health during the 4th quarter worth approximately $458,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on TDOC. Bank of America lowered their price target on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating for the company in a report on Wednesday. Jefferies Financial Group decreased their price objective on shares of Teladoc Health from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Monday, April 21st. Wells Fargo & Company dropped their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. Stifel Nicolaus cut their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a research note on Thursday, May 1st. Finally, The Goldman Sachs Group lowered their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $9.60.

Insiders Place Their Bets

In related news, insider Adam C. Vandervoort sold 11,011 shares of the stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.58% of the stock is owned by corporate insiders.

Teladoc Health Price Performance

Shares of NYSE TDOC traded up $0.02 during trading on Thursday, reaching $6.99. The company had a trading volume of 6,440,588 shares, compared to its average volume of 6,247,254. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health, Inc. has a twelve month low of $6.35 and a twelve month high of $15.21. The stock has a 50-day moving average price of $7.30 and a two-hundred day moving average price of $9.22. The stock has a market capitalization of $1.23 billion, a PE ratio of -1.21 and a beta of 1.82.

Teladoc Health (NYSE:TDOC - Get Free Report) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. As a group, sell-side analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.